Cubist Systematic Strategies, LLC Oncternal Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.56 $13,933 - $31,051	-19,905 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.37 - $2.43 $27,269 - $48,369	19,905 New	19,905 $28,000
Q3 2021 Nov 15, 2021	SELL	$3.37 - $4.76 $68,411 - $96,628	-20,300 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.75 - $9.39 $88,012 - $173,987	-18,529 Reduced 47.72%	20,300 $96,000
Q1 2021 May 17, 2021	BUY	$4.59 - $9.04 $178,225 - $351,014	38,829 New	38,829 $323,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.